An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
XVIIIth International Symposium on Atherosclerosis
June 9, 2018 - June 12, 2018
The ISA 2018 Symposium will be focused on cutting-edge research in the areas of atherosclerosis, thrombosis and vascular biology and will feature:
4-day program attracting 1500+ international professionals, organized in collaboration with opinion-leaders in atherosclerosis research from across the globe;
5 exciting program tracks including: Dyslipidemia, Epidemiology, Pathogenesis, Prevention and Therapeutics;
100+ internationally recognized speakers, leading plenary and parallel scientific sessions in basic, clinical and public health science of atherosclerosis; Global innovation and public health awareness forums;
Pre- and post-meeting satellite symposia;
Ground-breaking abstracts and scientific posters;
Networking and collaboration hubs;
Industry-sponsored social events, receptions, symposia, and faculty events;